Myelofibrosis constitutes a significant yet underrecognized challenge within global hematological disease management, representing a chronic myeloproliferative disorder that progressively destroys bone marrow architecture through pathological fibrosis development. This devastating condition fundamentally disrupts hematopoietic homeostasis, creating cascading health consequences that extend far...